Improving the survival of transplanted fat using gene therapy
Gene Therapy-mediated Angiogenesis to Enhance Survival of Transplanted Fat
This study is testing a new way to help fat grafts last longer in surgeries by using a special treatment that encourages blood vessel growth, which could lead to better results for patients getting these types of procedures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Enyx Therapeutics, LLC NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10912162 on NIH RePORTER |
What this research studies
This research focuses on enhancing the survival of autologous fat grafts, which are commonly used in reconstructive surgeries. The approach involves using a gene therapy technique to stimulate blood vessel growth in the transplanted fat, addressing a major reason for graft loss. By administering a specific adenovirus vector to the fat before transplantation, the therapy aims to significantly improve the graft's vascularization and longevity. This innovative method could lead to better outcomes for patients undergoing fat grafting procedures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals requiring soft tissue reconstruction, such as those with congenital deformities, traumatic injuries, or those undergoing oncologic surgery.
Not a fit: Patients who do not require fat grafting or those with conditions that contraindicate the use of gene therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective fat grafting techniques, resulting in improved aesthetic and functional outcomes for patients.
How similar studies have performed: While various strategies have been attempted to enhance fat graft survival, this specific gene therapy approach is novel and has not been previously tested in humans.
Where this research is happening
New York, United States
- Enyx Therapeutics, LLC — New York, United States (Active)
Researchers
- Principal investigator: Crystal, Ronald G — Enyx Therapeutics, LLC
- Study coordinator: Crystal, Ronald G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.